nature.com search

Loading Filters

Showing 1–36 of 36 results

Loading Filters

Amendments and Corrections | 13 May 2009
Erratum: Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants?
- R P Gale
- , M Eapen
- , B Logan
- , M-J Zhang
- & H M Lazarus
Bone Marrow Transplantation 43 , 743–743

Rights & permissionsfor article Erratum: Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants? . Opens in a new window.
Research | 18 April 2016
Autologous transplant remains the preferred therapy for relapsed APL in CR2
- C Ganzel
- , V Mathews
- , K Alimoghaddam
- , A Ghavamzadeh
- , D Kuk
- , S Devlin
- , H Wang
- , M-J Zhang
- , D Weisdorf
- , D Douer
- , J M Rowe
- , E Polge
- , J Esteve
- , A Nagler
- , M Mohty
- & M S Tallman
Bone Marrow Transplantation 51 , 1180–1183

Rights & permissionsfor article Autologous transplant remains the preferred therapy for relapsed APL in CR2 . Opens in a new window.
13 June 2017
Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004–2014
- A D'Souza
- , M-J Zhang
- , J Huang
- , M Fei
- , M Pasquini
- , M Hamadani
- & P Hari
Leukemia 31 , 1998–2000

Rights & permissionsfor article Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004–2014 . Opens in a new window.
Editorial | 26 August 2016
What is the (p-) value of the P-value?
- R P Gale
- , A Hochhaus
- & M-J Zhang
Leukemia 30 , 1965–1967

Rights & permissionsfor article What is the (p-) value of the P-value? . Opens in a new window.
11 July 2016
What is the P-value anyway?
- R P Gale
- & M-J Zhang
Bone Marrow Transplantation 51 , 1439–1440

Rights & permissionsfor article What is the P-value anyway? . Opens in a new window.
Amendments and Corrections | 26 February 2015
Erratum: TLR4-mediated inflammation promotes foam cell formation of vascular smooth muscle cell by upregulating ACAT1 expression
- Y-W Yin
- , S-Q Liao
- , M-J Zhang
- , Y Liu
- , B-H Li
- , Y Zhou
- , L Chen
- , C-Y Gao
- , J-C Li
- & L-L Zhang
Cell Death & Disease 6 , e1659–e1659

Rights & permissionsfor article Erratum: TLR4-mediated inflammation promotes foam cell formation of vascular smooth muscle cell by upregulating ACAT1 expression . Opens in a new window.
16 July 2014
Does ruxolitinib improve survival of persons with MPN-associated myelofibrosis? Should it?
- G Barosi
- , M-J Zhang
- & R Peter Gale
Leukemia 28 , 2267–2270

Rights & permissionsfor article Does ruxolitinib improve survival of persons with MPN-associated myelofibrosis? Should it? . Opens in a new window.
Research | 1 November 2011
Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research
- A Mahindra
- , M E Kalaycio
- , J Vela-Ojeda
- , D H Vesole
- , M-J Zhang
- , P Li
- , J R Berenson
- , J M Bird
- , A Dispenzieri
- , J L Gajewski
- , R P Gale
- , L Holmberg
- , S Kumar
- , R A Kyle
- , H M Lazarus
- , S Lonial
- , J Mikhael
- , G A Milone
- , R Munker
- , R Nath
- , S Saccaro
- , L Bik To
- , D T Vogl
- , B Wirk
- & P Hari
Leukemia 26 , 1091–1097

Rights & permissionsfor article Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research . Opens in a new window.
Research | 20 February 2006
Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia
- J R Passweg
- , W S Pérez
- , M Eapen
- , B M Camitta
- , E Gluckman
- , W Hinterberger
- , J M Hows
- , J C W Marsh
- , R Pasquini
- , H Schrezenmeier
- , G Socié
- , M-J Zhang
- & C Bredeson
Bone Marrow Transplantation 37 , 641–649

Rights & permissionsfor article Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia . Opens in a new window.
27 July 2016
HLA polymorphism and risk of multiple myeloma
- M Beksac
- , L Gragert
- , S Fingerson
- , M Maiers
- , M-J Zhang
- , M Albrecht
- , X Zhong
- , W Cozen
- , A Dispenzieri
- , S Lonial
- & P Hari
Leukemia 30 , 2260–2264

Rights & permissionsfor article HLA polymorphism and risk of multiple myeloma . Opens in a new window.
Research | 24 August 2015
Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation
- G L Uy
- , L J Costa
- , P N Hari
- , M-J Zhang
- , J-X Huang
- , K C Anderson
- , C N Bredeson
- , N S Callander
- , R F Cornell
- , M A D Perez
- , A Dispenzieri
- , C O Freytes
- , R P Gale
- , A Garfall
- , M A Gertz
- , J Gibson
- , M Hamadani
- , H M Lazarus
- , M E Kalaycio
- , R T Kamble
- , M A Kharfan-Dabaja
- , A Y Krishnan
- , S K Kumar
- , R A Kyle
- , H J Landau
- , C H Lee
- , A Maiolino
- , D I Marks
- , T M Mark
- , R Munker
- , T Nishihori
- , R F Olsson
- , M Ramanathan
- , T E Rodriguez
- , A A Saad
- , B N Savani
- , G J Schiller
- , H C Schouten
- , J R Schriber
- , E Scott
- , S Seo
- , M Sharma
- , S Ganguly
- , E A Stadtmauer
- , J Tay
- , L B To
- , D H Vesole
- , D T Vogl
- , J L Wagner
- , B Wirk
- , W A Wood
- & A D'Souza
Bone Marrow Transplantation 50 , 1513–1518

Rights & permissionsfor article Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation . Opens in a new window.
Research | 27 April 2015
Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome
- S D Goyal
- , M-J Zhang
- , H-L Wang
- , G Akpek
- , E A Copelan
- , C Freytes
- , R P Gale
- , M Hamadani
- , Y Inamoto
- , R T Kamble
- , H M Lazarus
- , D I Marks
- , T Nishihori
- , R F Olsson
- , R Reshef
- , D S Ritchie
- , W Saber
- , B N Savani
- , A Seber
- , T C Shea
- , M S Tallman
- , B Wirk
- , D W Bunjes
- , S M Devine
- , M de Lima
- , D J Weisdorf
- & G L Uy
Bone Marrow Transplantation 50 , 1057–1062

Rights & permissionsfor article Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome . Opens in a new window.
23 May 2013
Imatinib results in better outcomes than HLA-identical sibling transplants in young persons with newly diagnosed chronic-phase chronic myelogenous leukemia
- Q Jiang
- , L-P Xu
- , D-H Liu
- , K-Y Liu
- , R P Gale
- , M-J Zhang
- , B Jiang
- , X-H Zhang
- , Y Wang
- , S-S Chen
- , X-Y Zhao
- , H Chen
- , H Jiang
- , Y-H Chen
- , W Han
- , Y-Z Qin
- , Y-R Liu
- , Y-Y Lai
- , M Lv
- & X-J Huang
Leukemia 27 , 2410–2413

Rights & permissionsfor article Imatinib results in better outcomes than HLA-identical sibling transplants in young persons with newly diagnosed chronic-phase chronic myelogenous leukemia . Opens in a new window.
Research | 22 November 2007
Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research
- M Eapen
- , M-J Zhang
- , M Devidas
- , E Raetz
- , J C Barredo
- , A K Ritchey
- , K Godder
- , S Grupp
- , V A Lewis
- , K Malloy
- , W L Carroll
- , S M Davies
- & B M Camitta
Leukemia 22 , 281–286

Rights & permissionsfor article Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research . Opens in a new window.
Research | 19 May 2008
Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population
- J E Levine
- , A J Barrett
- , M-J Zhang
- , M Arora
- , M A Pulsipher
- , N Bunin
- , J Fort
- , F Loberiza
- , D Porter
- , S Giralt
- , W Drobyski
- , D Wang
- , S Pavletic
- , O Ringden
- , M M Horowitz
- & R Collins Jr
Bone Marrow Transplantation 42 , 201–205

Rights & permissionsfor article Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population . Opens in a new window.
Research | 26 March 2009
Is the international staging system superior to the Durie–Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant
- P N Hari
- , M-J Zhang
- , V Roy
- , W S Pérez
- , A Bashey
- , L B To
- , G Elfenbein
- , C O Freytes
- , R P Gale
- , J Gibson
- , R A Kyle
- , H M Lazarus
- , P L McCarthy
- , G A Milone
- , S Pavlovsky
- , D E Reece
- , G Schiller
- , J Vela-Ojeda
- , D Weisdorf
- & D Vesole
Leukemia 23 , 1528–1534

Rights & permissionsfor article Is the international staging system superior to the Durie–Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant . Opens in a new window.
Research | 17 December 2007
Allogeneic hematopoietic cell transplantation for metastatic breast cancer
- N T Ueno
- , J D Rizzo
- , T Demirer
- , Y C Cheng
- , U Hegenbart
- , M-J Zhang
- , M Bregni
- , A Carella
- , D Blaise
- , A Bashey
- , J D Bitran
- , B J Bolwell
- , G J Elfenbein
- , K K Fields
- , C O Freytes
- , R P Gale
- , H M Lazarus
- , R E Champlin
- , P J Stiff
- & D Niederwieser
Bone Marrow Transplantation 41 , 537–545

Rights & permissionsfor article Allogeneic hematopoietic cell transplantation for metastatic breast cancer . Opens in a new window.
Reviews | 17 December 2001
Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling
- JP Klein
- , JD Rizzo
- , M-J Zhang
- & N Keiding
Bone Marrow Transplantation 28 , 1001–1011

Rights & permissionsfor article Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling . Opens in a new window.
Research | 1 December 2003
Autologous stem cell transplantation in multiple myeloma patients <60 vs ⩾60 years of age
- D E Reece
- , C Bredeson
- , W S Pérez
- , S Jagannath
- , M J Zhang
- , K K Ballen
- , G J Elfenbein
- , C O Freytes
- , R P Gale
- , M A Gertz
- , J Gibson
- , S A Giralt
- , A Keating
- , R A Kyle
- , D Maharaj
- , D Marcellus
- , P L McCarthy
- , G A Milone
- , S D Nimer
- , S Pavlovsky
- , L B To
- , D J Weisdorf
- , P H Wiernik
- , J R Wingard
- & D H Vesole
Bone Marrow Transplantation 32 , 1135–1143

Rights & permissionsfor article Autologous stem cell transplantation in multiple myeloma patients <60 vs ⩾60 years of age . Opens in a new window.
Research | 7 December 2010
Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation
- A B M Madureira
- , M Eapen
- , F Locatelli
- , P Teira
- , M-J Zhang
- , S M Davies
- , A Picardi
- , A Woolfrey
- , K-W Chan
- , G Socié
- , A Vora
- , Y Bertrand
- , C M Sales-Bonfim
- , E Gluckman
- , C Niemeyer
- & V Rocha
Leukemia 25 , 449–454

Rights & permissionsfor article Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation . Opens in a new window.
Research | 20 April 2001
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)
- HM Lazarus
- , FR Loberiza Jr
- , M-J Zhang
- , JO Armitage
- , KK Ballen
- , A Bashey
- , BJ Bolwell
- , LJ Burns
- , CO Freytes
- , RP Gale
- , J Gibson
- , RH Herzig
- , CF LeMaistre
- , D Marks
- , J Mason
- , AM Miller
- , GA Milone
- , S Pavlovsky
- , DE Reece
- , JD Rizzo
- , K van Besien
- , JM Vose
- & MM Horowitz
Bone Marrow Transplantation 27 , 387–396

Rights & permissionsfor article Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR) . Opens in a new window.
Research | 18 February 1998
Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia
- JR Passweg
- , P Tiberghien
- , J-Y Cahn
- , MR Vowels
- , BM Camitta
- , RP Gale
- , RH Herzig
- , D Hoelzer
- , MM Horowitz
- , N Ifrah
- , JP Klein
- , DI Marks
- , NKC Ramsay
- , PA Rowlings
- , DJ Weisdorf
- , M-J Zhang
- & AJ Barrett
Bone Marrow Transplantation 21 , 153–158

Rights & permissionsfor article Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia . Opens in a new window.
Research | 13 August 1998
Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission
- H Oh
- , RP Gale
- , M-J Zhang
- , JR Passweg
- , T Ino
- , H Murakami
- , R Ohno
- , PA Rowlings
- , KA Sobocinski
- , M Tanimoto
- , M Tomonaga
- , DJ Weisdorf
- & MM Horowitz
Bone Marrow Transplantation 22 , 253–257

Rights & permissionsfor article Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission . Opens in a new window.
Research | 11 August 2008
Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation
- L-R Wang
- , L-J Dong
- , M-J Zhang
- & D-P Lu
Bone Marrow Transplantation 42 , 673–677

Rights & permissionsfor article Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation . Opens in a new window.
Research | 26 September 2011
Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma
- O Ringdén
- , S Shrestha
- , G T da Silva
- , M-J Zhang
- , A Dispenzieri
- , M Remberger
- , R Kamble
- , C O Freytes
- , R P Gale
- , J Gibson
- , V Gupta
- , L Holmberg
- , H Lazarus
- , P McCarthy
- , K Meehan
- , H Schouten
- , G A Milone
- , S Lonial
- & P N Hari
Bone Marrow Transplantation 47 , 831–837

Rights & permissionsfor article Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma . Opens in a new window.
Reviews | 29 November 2001
Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: Unadjusted analysis
- JP Klein
- , JD Rizzo
- , M-J Zhang
- & N Keiding
Bone Marrow Transplantation 28 , 909–915

Rights & permissionsfor article Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: Unadjusted analysis . Opens in a new window.
Research | 16 November 2009
Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation
- P J Shaughnessy
- , B J Bolwell
- , K van Besien
- , M Mistrik
- , A Grigg
- , A Dodds
- , H M Prince
- , S Durrant
- , O Ilhan
- , D Parenti
- , J Gallo
- , F Foss
- , J Apperley
- , M-J Zhang
- , M M Horowitz
- & S Abhyankar
Bone Marrow Transplantation 45 , 1068–1076

Rights & permissionsfor article Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation . Opens in a new window.
Research | 17 May 2010
High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR
- N S Majhail
- , R Bajorunaite
- , H M Lazarus
- , Z Wang
- , J P Klein
- , M J Zhang
- & J D Rizzo
Bone Marrow Transplantation 46 , 385–392

Rights & permissionsfor article High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR . Opens in a new window.
Research | 23 August 2004
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant
- M Eapen
- , S A Giralt
- , M M Horowitz
- , J P Klein
- , J E Wagner
- , M-J Zhang
- , M S Tallman
- , D I Marks
- , B M Camitta
- , R E Champlin
- , O Ringdén
- , C N Bredeson
- , R Martino
- , R P Gale
- , M S Cairo
- , M R Litzow
- & M deLima
Bone Marrow Transplantation 34 , 721–727

Rights & permissionsfor article Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant . Opens in a new window.
Research | 18 June 1998
Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia
- JR Passweg
- , PA Rowlings
- , KA Atkinson
- , AJ Barrett
- , RP Gale
- , A Gratwohl
- , N Jacobsen
- , JP Klein
- , P Ljungman
- , JA Russell
- , UW Schaefer
- , KA Sobocinski
- , JM Vossen
- , M-J Zhang
- & MM Horowitz
Bone Marrow Transplantation 21 , 1231–1238

Rights & permissionsfor article Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia . Opens in a new window.
Research | 30 August 2013
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease
- V Bachanova
- , D I Marks
- , M-J Zhang
- , H Wang
- , M de Lima
- , M D Aljurf
- , M Arellano
- , A S Artz
- , U Bacher
- , J-Y Cahn
- , Y-B Chen
- , E A Copelan
- , W R Drobyski
- , R P Gale
- , J P Greer
- , V Gupta
- , G A Hale
- , P Kebriaei
- , H M Lazarus
- , I D Lewis
- , V A Lewis
- , J L Liesveld
- , M R Litzow
- , A W Loren
- , A M Miller
- , M Norkin
- , B Oran
- , J Pidala
- , J M Rowe
- , B N Savani
- , W Saber
- , R Vij
- , E K Waller
- , P H Wiernik
- & D J Weisdorf
Leukemia 28 , 658–665

Rights & permissionsfor article Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease . Opens in a new window.
Research | 25 January 2017
Outcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysis
- C Ustun
- , F Giannotti
- , M-J Zhang
- , H-L Wang
- , C Brunstein
- , M Labopin
- , V Rocha
- , M de Lima
- , F Baron
- , B M Sandmaier
- , M Eapen
- , E Gluckman
- , A Nagler
- , D J Weisdorf
- & A Ruggeri
Leukemia 31 , 1408–1414

Rights & permissionsfor article Outcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysis . Opens in a new window.
Research | 18 December 2014 | Open
TLR4-mediated inflammation promotes foam cell formation of vascular smooth muscle cell by upregulating ACAT1 expression
- Y-W Yin
- , S-Q Liao
- , M-J Zhang
- , Y Liu
- , B-H Li
- , Y Zhou
- , L Chen
- , C-Y Gao
- , J-C Li
- & L-L Zhang
Cell Death & Disease 5 , e1574–e1574

Rights & permissionsfor article TLR4-mediated inflammation promotes foam cell formation of vascular smooth muscle cell by upregulating ACAT1 expression . Opens in a new window.
Research | 28 March 2011
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS
- S M Luger
- , O Ringdén
- , M-J Zhang
- , W S Pérez
- , M R Bishop
- , M Bornhauser
- , C N Bredeson
- , M S Cairo
- , E A Copelan
- , R P Gale
- , S A Giralt
- , Z Gulbas
- , V Gupta
- , G A Hale
- , H M Lazarus
- , V A Lewis
- , M C Lill
- , P L McCarthy
- , D J Weisdorf
- & M A Pulsipher
Bone Marrow Transplantation 47 , 203–211

Rights & permissionsfor article Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS . Opens in a new window.
Research | 2 July 2003
IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial
- L J Burns
- , D J Weisdorf
- , T E DeFor
- , D H Vesole
- , T L Repka
- , B R Blazar
- , S R Burger
- , A Panoskaltsis-Mortari
- , C A Keever-Taylor
- , M-J Zhang
- & J S Miller
Bone Marrow Transplantation 32 , 177–186

Rights & permissionsfor article IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial . Opens in a new window.
2 February 2009
Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants?
- R P Gale
- , M Eapen
- , B Logan
- , M-J Zhang
- & H M Lazarus
Bone Marrow Transplantation 43 , 435–446

Rights & permissionsfor article Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants? . Opens in a new window.

Refine your results by…

Filters

Filter By:

Erratum: Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants?

Autologous transplant remains the preferred therapy for relapsed APL in CR2

Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004–2014

What is the (p-) value of the P-value?

What is the P-value anyway?

Erratum: TLR4-mediated inflammation promotes foam cell formation of vascular smooth muscle cell by upregulating ACAT1 expression

Does ruxolitinib improve survival of persons with MPN-associated myelofibrosis? Should it?

Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research

Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia

HLA polymorphism and risk of multiple myeloma

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation

Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome

Imatinib results in better outcomes than HLA-identical sibling transplants in young persons with newly diagnosed chronic-phase chronic myelogenous leukemia

Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population

Is the international staging system superior to the Durie–Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant

Allogeneic hematopoietic cell transplantation for metastatic breast cancer

Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling

Autologous stem cell transplantation in multiple myeloma patients <60 vs ⩾60 years of age

Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation

Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)

Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia

Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission

Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation

Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma

Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: Unadjusted analysis

Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation

High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant

Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia

Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease

Outcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysis

TLR4-mediated inflammation promotes foam cell formation of vascular smooth muscle cell by upregulating ACAT1 expression

Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS

IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial

Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants?

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters